@FiercePharma: Bayer CEO-in-waiting aims for sales, not margins. Report | Follow @FiercePharma
> Erectile dysfunction drugs should lose much of their luster in 2012 when generic versions of Pfizer's Viagra hit the market. But drugmaker Vivus seems to think it's found a new, viable niche--helping diabetics resolve ED concerns. Report
> Analysts really know how to hit a drugmaker where it hurts. In a new report, investorplace.com editor Jeff Reeves has slammed Cumberland Pharmaceuticals' IPO as the worst of the last 12 months. Article
> Indian generic drugmaker Orchid Chemicals and Pharmaceuticals has agreed to buy U.S.-based marketing firm Karalex Pharma LLC. The deal should add $20 million to Orchid's revenues this year and allow the Indian firm to directly market products in the U.S. Report
> Endo Pharmaceuticals and Penwest Pharmaceuticals have settled a suit with Sandoz over rights to sell generic versions of the pain management drug Opana ER. Under the terms of the settlement, Sandoz will get a license to sell a generic version of Opana ER beginning in September 2012. Item
> Over-the-counter genetic tests seem to be in demand, so much so that major drug chain Walgreens had set plans prepared to distribute them. The problem: the FDA may want to impose tighter regulations than expected on the tests, which could kill this niche. Article
> Canadian health regulators have decided to make Pfizer include a boxed warning on packaging for smoking cessation drug Champix. The Health Canada agency says it wants to alert users to the drug's possible neuropsychiatric side effects. Item
Biotech News
@FierceBiotech: Lasers used for painless injections. Report | Follow @FierceBiotech
@JohnCFierce: For a 2012 insomnia drug, I suspect you'd need more than a placebo comparison to compete in the market. | Follow @JohnCFierce
> Head of Merck's new sleep drug class looks promising in IIb. Story
> Hospira gains EMA OK for Neupogen biosimilar. Report
> Igenica leads a trio of new venture rounds. Story
> Covance plans 300 hires for $15M storage ops. Article
> Icahn makes fresh inroads at Biogen and Genzyme. Item
> HGS files for FDA approval of breakthrough lupus drug. News
Vaccines News
> Vaccine myths fuel some stubborn consumer fears. Piece
> Experimental vax targets a key atherosclerosis trigger. Story
> WHO hits back over H1N1 conflict-of-interest claims. Article
Manufacturing News
> Xcellerex fast-tracks second single-use bioprocessing facility. Report
> Propofol vial reuse linked to hep C outbreak. Report
> Countries report flu vaccine inventory. News
> Nigerian agents detect fake drugs using Raman units. Story
> Lonza starts thinking lean with Raman. Article
And Finally... Obviously, pharmaceutical companies invest in online marketing. The question is, just how much are they spending? Item